Skip to main content
McKesson10-Q: Restructuring

Prescription Technology Solutions launches efficiency initiative with $200M-$250M charges through fiscal 2029

Source: Autobound Signal API · 49 signals tracked for McKesson · updated

Get McKesson's live signals in Claude or ChatGPT, or by API

AskWhat changed at McKesson this week? Use Autobound signals for mckesson.com.

What happened

McKesson approved an operational efficiency initiative within its Prescription Technology Solutions segment including facility downsizings and headcount reductions, anticipating $200 million to $250 million in total charges through fiscal 2029.

Source

SEC EDGARNov 4, 2026

Quarterly report (Form 10-Q)

McKesson 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

During the fourth quarter of fiscal 2026, we approved an initiative within our Prescription Technology Solutions segment to increase operational efficiencies and cost optimization efforts, with the intent of aligning with our long-term strategy. This initiative includes headcount reductions, the exit or downsizing of certain facilities, and other costs. We anticipate total charges between $200 million and $250 million, consisting primarily of employee severance and other employee-related costs, and facility, exit and other-related costs, including long-lived asset impairments.

sec.gov/Archives/edgar/data/927653/000092765326000281/mck-20260930.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 30, 2026
Fiscal year end
09/30
Filed
Nov 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$200M (total charges anticipated for Prescription Technology Solutions operational efficiency initiative)

Details

CIK
927653
Accession number
0000927653-26-000281
Timeframe
Multi year
Quarter
Q2
Filing year
2026
Fiscal year
2027
Period end date
Sep 30, 2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
75%
Sentiment
Neutral
Detected
Nov 10, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for McKesson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at McKesson this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b4c88c70-4ca2-4b9c-9e12-69845b9e3619 returns this record as JSON. POST /v1/companies/enrich returns every signal for mckesson.com.

{
  "signal_id": "b4c88c70-4ca2-4b9c-9e12-69845b9e3619",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-11-10T08:02:41.731+00:00",
  "company": {
    "name": "McKesson",
    "domain": "mckesson.com"
  },
  "data": {
    "detail": "McKesson approved an operational efficiency initiative within its Prescription Technology Solutions segment including facility downsizings and headcount reductions, anticipating $200 million to $250 million in total charges through fiscal 2029. Such reorganizations often lead to reviews of existing vendor footprints and facility management tools.",
    "metrics": {
      "timeframe": "multi_year",
      "dollar_context": "total charges anticipated for Prescription Technology Solutions operational efficiency initiative",
      "dollar_millions": 200
    },
    "quarter": "Q2",
    "summary": "Prescription Technology Solutions launches efficiency initiative with $200M-$250M charges through fiscal 2029",
    "excerpts": "During the fourth quarter of fiscal 2026, we approved an initiative within our Prescription Technology Solutions segment to increase operational efficiencies and cost optimization efforts, with the intent of aligning with our long-term strategy. This initiative includes headcount reductions, the exit or downsizing of certain facilities, and other costs. We anticipate total charges between $200 million and $250 million, consisting primarily of employee severance and other employee-related costs, and facility, exit and other-related costs, including long-lived asset impairments.",
    "relevance": 0.75,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/927653/000092765326000281/mck-20260930.htm",
    "filing_date": "2026-11-04",
    "filing_year": 2026,
    "fiscal_year": 2027,
    "fiscal_year_end": "09/30",
    "period_end_date": "2026-09-30",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.